Overview

A Study of LY2951742 in Participants With Mild to Moderate Osteoarthritis Knee Pain

Status:
Terminated
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to test if LY2951742 relieves mild to moderate knee pain. The study drugs will be given as an injection under the skin and as an oral capsule. The study will last about 28 weeks for each participant.
Phase:
Phase 2
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Celecoxib